rs763587293

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6

The NM_001291415.2(KDM6A):​c.1677A>C​(p.Gln559His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 112,478 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000027 ( 0 hom., 0 hem., cov: 23)
Exomes š‘“: 0.0000029 ( 0 hom. 2 hem. )
Failed GnomAD Quality Control

Consequence

KDM6A
NM_001291415.2 missense

Scores

5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 2.18

Publications

1 publications found
Variant links:
Genes affected
KDM6A (HGNC:12637): (lysine demethylase 6A) This gene is located on the X chromosome and is the corresponding locus to a Y-linked gene which encodes a tetratricopeptide repeat (TPR) protein. The encoded protein of this gene contains a JmjC-domain and catalyzes the demethylation of tri/dimethylated histone H3. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Apr 2014]
KDM6A Gene-Disease associations (from GenCC):
  • Kabuki syndrome 2
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19937742).
BP6
Variant X-45062742-A-C is Benign according to our data. Variant chrX-45062742-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 520720.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KDM6ANM_001291415.2 linkc.1677A>C p.Gln559His missense_variant Exon 16 of 30 ENST00000611820.5 NP_001278344.1 A0A087X0R0B7ZKN5Q86TD1B7ZKN6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KDM6AENST00000611820.5 linkc.1677A>C p.Gln559His missense_variant Exon 16 of 30 1 NM_001291415.2 ENSP00000483595.2 A0A087X0R0

Frequencies

GnomAD3 genomes
AF:
0.0000267
AC:
3
AN:
112478
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000188
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000657
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000289
AC:
3
AN:
1039225
Hom.:
0
Cov.:
23
AF XY:
0.00000639
AC XY:
2
AN XY:
312901
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25294
American (AMR)
AF:
0.00
AC:
0
AN:
35094
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18973
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29932
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52693
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40485
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3926
European-Non Finnish (NFE)
AF:
0.00000254
AC:
2
AN:
788659
Other (OTH)
AF:
0.0000226
AC:
1
AN:
44169
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000267
AC:
3
AN:
112478
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34616
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30972
American (AMR)
AF:
0.000188
AC:
2
AN:
10613
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3596
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2761
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6118
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
235
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53322
Other (OTH)
AF:
0.000657
AC:
1
AN:
1523
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000162
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Kabuki syndrome 2 Uncertain:2
Oct 25, 2018
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2. This variant was detected in hemizygous state. -

Oct 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 507 of the KDM6A protein (p.Gln507His). This variant is present in population databases (rs763587293, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with KDM6A-related conditions. ClinVar contains an entry for this variant (Variation ID: 520720). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KDM6A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Uncertain:1
Aug 06, 2015
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Apr 09, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.031
.;.;T;T
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.81
T;T;T;T
M_CAP
Benign
0.041
D
MetaRNN
Benign
0.20
T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Uncertain
2.2
.;.;.;M
PhyloP100
2.2
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-1.4
.;.;.;N
REVEL
Benign
0.074
Sift
Uncertain
0.0010
.;.;.;D
Sift4G
Benign
0.099
T;T;D;T
Polyphen
0.0010
.;.;.;B
Vest4
0.26
MVP
0.48
MPC
0.11
ClinPred
0.87
D
GERP RS
3.2
Varity_R
0.40
gMVP
0.81
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs763587293; hg19: chrX-44921987; API